JP2022526364A5 - - Google Patents
Info
- Publication number
- JP2022526364A5 JP2022526364A5 JP2021557761A JP2021557761A JP2022526364A5 JP 2022526364 A5 JP2022526364 A5 JP 2022526364A5 JP 2021557761 A JP2021557761 A JP 2021557761A JP 2021557761 A JP2021557761 A JP 2021557761A JP 2022526364 A5 JP2022526364 A5 JP 2022526364A5
- Authority
- JP
- Japan
- Prior art keywords
- independently selected
- substituted
- pharmaceutically acceptable
- acceptable salt
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1904373.6A GB201904373D0 (en) | 2019-03-29 | 2019-03-29 | Novel compounds and pharamaceutical compositions thereof for the treatment of inflammatory disorders |
| GB1904373.6 | 2019-03-29 | ||
| PCT/EP2020/058064 WO2020200900A1 (en) | 2019-03-29 | 2020-03-24 | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022526364A JP2022526364A (ja) | 2022-05-24 |
| JP2022526364A5 true JP2022526364A5 (cg-RX-API-DMAC7.html) | 2023-04-03 |
Family
ID=66442982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557761A Pending JP2022526364A (ja) | 2019-03-29 | 2020-03-24 | 炎症性障害の治療のための新規化合物及びその医薬組成物 |
Country Status (18)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201904375D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| GB201904374D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
| CN113243338A (zh) * | 2021-05-14 | 2021-08-13 | 福州大学 | 一种小鼠缺血性卒中模型的构建与评估方法 |
| CN117177965B (zh) | 2021-12-23 | 2024-04-30 | 杭州多域生物技术有限公司 | 一种五元并六元化合物、制备方法、药物组合物和应用 |
| EP4389747A1 (en) * | 2022-12-21 | 2024-06-26 | Dark Blue Therapeutics Ltd | Imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives as mllt1 and mllt3 inhibitors |
| EP4638447A1 (en) * | 2022-12-21 | 2025-10-29 | Dark Blue Therapeutics Ltd | Imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives as mllt1 and mllt3 inhibitors |
| CN119751445B (zh) * | 2024-12-10 | 2025-11-25 | 江南大学 | 6-乙炔基吡唑并[1,5-a]吡啶的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005016928A1 (ja) * | 2003-08-15 | 2005-02-24 | Banyu Pharmaceutical Co., Ltd. | イミダゾピリジン誘導体 |
| US7566781B2 (en) * | 2004-05-10 | 2009-07-28 | Banyu Pharmaceutical Co., Ltd. | Imidazopyridine compound |
| EP2688872A4 (en) * | 2011-03-22 | 2014-08-27 | Merck Sharp & Dohme | AMIDOPYRAZOLHEMMER OF INTERLEUKIN RECEPTOR-MEDIATED KINASES |
| GB201401086D0 (en) * | 2014-01-23 | 2014-03-12 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
| CA2992406A1 (en) * | 2015-07-15 | 2017-01-19 | Aurigene Discovery Technologies Limited | Indazole and azaindazole compounds as irak-4 inhibitors |
| GB201518456D0 (en) * | 2015-10-19 | 2015-12-02 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory, autoimmune and/or proliferative diseases |
| WO2018060174A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln |
| WO2018060072A1 (de) * | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Neue substituierte benzimidazole, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
| WO2018083085A1 (en) * | 2016-11-02 | 2018-05-11 | F. Hoffmann-La Roche Ag | PYRAZOLO[1,5a]PYRIMIDINE DERIVATIVES AS IRAK4 MODULATORS |
| CN110835338A (zh) * | 2018-08-17 | 2020-02-25 | 浙江海正药业股份有限公司 | 咪唑并吡啶类衍生物及其制备方法和其在医药上的用途 |
| JP7576552B2 (ja) * | 2019-01-18 | 2024-10-31 | バイオジェン・エムエイ・インコーポレイテッド | イミダゾ[1,2-a]ピリジニル誘導体及び疾患の処置におけるその使用 |
| GB201904374D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compunds and pharmaceutical composistions thereof for the treatment of inflammatory disorders |
| GB201904375D0 (en) * | 2019-03-29 | 2019-05-15 | Galapagos Nv | Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders |
-
2019
- 2019-03-29 GB GBGB1904373.6A patent/GB201904373D0/en not_active Ceased
-
2020
- 2020-03-24 EP EP20715295.0A patent/EP3947378B1/en active Active
- 2020-03-24 PH PH1/2021/552375A patent/PH12021552375A1/en unknown
- 2020-03-24 CN CN202080025098.XA patent/CN113646305A/zh active Pending
- 2020-03-24 KR KR1020217035254A patent/KR20210145238A/ko not_active Ceased
- 2020-03-24 SG SG11202110644WA patent/SG11202110644WA/en unknown
- 2020-03-24 US US17/599,465 patent/US20220218679A1/en not_active Abandoned
- 2020-03-24 BR BR112021019055A patent/BR112021019055A2/pt not_active IP Right Cessation
- 2020-03-24 WO PCT/EP2020/058064 patent/WO2020200900A1/en not_active Ceased
- 2020-03-24 JP JP2021557761A patent/JP2022526364A/ja active Pending
- 2020-03-24 MA MA055497A patent/MA55497A/fr unknown
- 2020-03-24 AU AU2020252038A patent/AU2020252038A1/en not_active Abandoned
- 2020-03-24 CA CA3134736A patent/CA3134736A1/en active Pending
- 2020-03-24 MX MX2021011576A patent/MX2021011576A/es unknown
- 2020-03-27 TW TW109110404A patent/TW202102501A/zh unknown
- 2020-03-27 AR ARP200100870A patent/AR118521A1/es not_active Application Discontinuation
-
2021
- 2021-09-26 IL IL286677A patent/IL286677A/en unknown
- 2021-10-25 CO CONC2021/0014223A patent/CO2021014223A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2289691T3 (es) | Derivados de sulfonamida para el tratamiento de enfermedades. | |
| AU2019260159B2 (en) | HPK1 inhibitors, preparation method and application thereof | |
| US20050197357A1 (en) | Anticholinergics which may be used as medicaments as well as processes for preparing them | |
| CN103987708B (zh) | 4-羟基-1,2,3,4-四氢萘-1-基脲的衍生物及其在呼吸道疾病治疗中的用途 | |
| JP2015514794A (ja) | 新規化合物 | |
| JP2015519319A (ja) | 新規化合物 | |
| KR20130079379A (ko) | 11(베타)-hsd1의 억제제로서 3,3-이치환된-(8-아자-비시클로[3.2.1]옥트-8-일)-[5-(1h-피라졸-4-일)-티오펜-3-일]-메탄온 | |
| CA2918284A1 (en) | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core | |
| CN103974953B (zh) | 激酶抑制剂 | |
| EP4103564A1 (en) | P2x3 modulators | |
| JP7842612B2 (ja) | 臭化ウメクリジニウムの調製プロセス | |
| JP2019532054A (ja) | Trpv4拮抗薬 | |
| JP2023532298A (ja) | 化合物、組成物及び方法 | |
| JP2015528488A (ja) | 脾臓チロシンキナーゼi(syk)阻害剤としての2−(2−アミノシクロヘキシル)アミノピリミジン−5−カルボキサミド類 | |
| JP2022526176A5 (cg-RX-API-DMAC7.html) | ||
| US20160168119A1 (en) | Autotaxin inhibitors | |
| CA3129851A1 (en) | Substituted amide compounds useful as farnesoid x receptor modulators | |
| CA3087994A1 (en) | 4-methyldihydropyrimidinone compounds and pharmaceutical use thereof | |
| JP2020500918A (ja) | Nrf2レギュレーターとしてのn−アリールピラゾール | |
| KR20100047333A (ko) | 아세트아미드 입체이성체 | |
| AU2012277514A1 (en) | Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders | |
| CN102388025A (zh) | 用作p38mapk抑制剂的嘧啶并哒嗪衍生物 | |
| CN107207407A (zh) | 用于治疗疾病和病症的组合物和方法 | |
| EP1831210A1 (en) | 8-aza-bicyclo[3.2.1]octane derivatives with an activity on chemokine ccr5 receptors | |
| CN106232613A (zh) | 选择性糖皮质激素受体配体 |